Literature DB >> 22185944

Prevalence of leptospira in acute hepatitis syndrome and assessment of IL-8 and TNF-alpha level in leptospiral hepatitis.

M Rizvi1, M Azam, M R Ajmal, I Shukla, A Malik.   

Abstract

To study the prevalence of leptospira in acute hepatitis syndrome and to assess interleukin (IL)-8 and tumour necrosis factor (TNF)-alpha levels in the pathogenesis of hepatitis due to leptospiral infection. Two hundred and forty-seven consecutive cases with symptoms of acute hepatitis and 30 healthy controls were enrolled in the study and detailed clinical history was elicited from them. Enzyme-linked immunosorbent assays (ELISAs) for HAV, HBV, HCV and HEV were performed to rule out common viral aetiology of hepatitis. IgM antibodies to leptospira were detected by ELISA. IL-8 and TNF-alpha levels were estimated in leptospira-positive cases and healthy controls by ELISA. Out of 247 cases of acute hepatitis, 46 (18.62%) were observed to be positive for IgM antibodies for leptospira. The mean age of these patients was 31.99 ± 0.28 years (25 males and 21 females; M/F ratio: 1.19:1). The mean ALT, AST and ASP were raised in the majority of patients. IL-8 was found to be elevated (130.81 pg/ml) in a large majority of cases 41/46, 89.1% (P < 0.001). Patients with more severe symptoms were associated with higher levels of IL-8. One mortality was observed due to leptospira. Unpredictably, TNF-alpha level was largely suppressed (45.63 pg/ml) in most of the leptospira-positive patients in comparison with healthy controls. Leptospira-induced hepatitis should be actively looked for in patients negative for A-E viral hepatitis. IL-8 appears to play an important role in the pathogenesis of leptospiral hepatitis. High TNF-alpha should alert clinicians for aggressive in hospital management of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22185944      PMCID: PMC4100316          DOI: 10.1179/1364859411Y.0000000041

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  18 in total

1.  Detection of dengue infection in patients investigated for leptospirosis in Barbados.

Authors:  P N Levett; S L Branch; C N Edwards
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

2.  Interleukin 12 in part regulates gamma interferon release in human whole blood stimulated with Leptospira interrogans.

Authors:  Maaike de Fost; Rudy A Hartskeerl; Martijn R Groenendijk; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  An urban outbreak of leptospirosis in Mumbai, India.

Authors:  Renu Bharadwaj; Abhijit M Bal; Suvarna A Joshi; Anju Kagal; Sae S Pol; Gajanan Garad; Vidya Arjunwadkar; Ravindra Katti
Journal:  Jpn J Infect Dis       Date:  2002-12       Impact factor: 1.362

4.  Multiplex PCR-based detection of Leptospira in environmental water samples obtained from a slum settlement.

Authors:  Juliana Magalhães Vital-Brazil; Ilana Teruszkin Balassiano; Fabiano Sutter de Oliveira; Alberto Dias de Souza Costa; Leandro Hillen; Martha Maria Pereira
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-05       Impact factor: 2.743

5.  Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome.

Authors:  Ioannis Kyriakidis; Pinelopi Samara; Anna Papa
Journal:  Cytokine       Date:  2011-02-12       Impact factor: 3.861

6.  The importance of leptospirosis in Southeast Asia.

Authors:  Kanti Laras; Bao Van Cao; Khanthong Bounlu; Thi Kim Tien Nguyen; James G Olson; Sisouk Thongchanh; Nguyen Van Anh Tran; Kim Loan Hoang; Narain Punjabi; Ba Khiem Ha; Sam An Ung; Sithat Insisiengmay; Douglas M Watts; H James Beecham; Andrew L Corwin
Journal:  Am J Trop Med Hyg       Date:  2002-09       Impact factor: 2.345

7.  Referral pattern of leptospirosis cases during a large urban epidemic of dengue.

Authors:  B Flannery; M M Pereira; F Velloso L de; C Carvalho C de; L G De Codes; S Orrico G de; C M Dourado; L W Riley; M G Reis; A I Ko
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

8.  Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.

Authors:  S J Polyak; K S Khabar; M Rezeiq; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic.

Authors:  Urmimala Sarkar; Simone F Nascimento; Rosan Barbosa; Ridalva Martins; Hector Nuevo; Ippolytos Kalofonos; Ippolytos Kalafanos; Itamar Grunstein; Brendan Flannery; Juarez Dias; Lee W Riley; Mitermayer G Reis; Albert I Ko
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

10.  Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira.

Authors:  Alisa Lowanitchapat; Sunchai Payungporn; Amornpun Sereemaspun; Pattama Ekpo; Duangporn Phulsuksombati; Yong Poovorawan; Chintana Chirathaworn
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-06-25       Impact factor: 2.268

View more
  10 in total

1.  Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis.

Authors:  Magdalena Sarah Volz; Verena Moos; Kristina Allers; Enno Luge; Anne Mayer-Scholl; Karsten Nöckler; Christoph Loddenkemper; Andreas Jansen; Thomas Schneider
Journal:  Clin Vaccine Immunol       Date:  2015-10-21

Review 2.  Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review.

Authors:  Krishnan Baby Karpagam; Balasubramanian Ganesh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

3.  Raised levels of Il-6, Il-17a, and Il-22 in fatal leptospirosis.

Authors:  Wan Shahriman Yushdie Wan Yusoff; Maha Abdullah; Zamberi Sekawi; Fairuz Amran; Muhammad Yazli Yuhana; Niazlin Mohd Taib; Ivan Kok Seng Yap; Leslie Thian Lung Than; Anim Md Shah; Alex van Belkum; Syafinaz Amin Nordin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-16       Impact factor: 3.267

4.  Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers.

Authors:  Loic Raffray; Claude Giry; David Vandroux; Barbara Kuli; Andry Randrianjohany; Anne-Marie Pequin; Frédéric Renou; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

5.  Leptospira Exposure and Patients with Liver Diseases: A Case-Control Seroprevalence Study.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco; Agar Ramos-Nevárez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola
Journal:  Int J Biomed Sci       Date:  2016-06

6.  Seroprevalence trends of Scrub typhus among the febrile patients of Northern India: A prospective cross-sectional study.

Authors:  Sweta Singh; Sangram Singh Patel; Chinmoy Sahu; Ujjala Ghoshal
Journal:  J Family Med Prim Care       Date:  2021-07-30

7.  Can cytokines response play a role in the treatment of fatal leptospirosis?

Authors:  Ahmad Alikhani; Kimia Mahmoodi; Leyla Delavaryan; Ebrahim Salehifar; Ali Reza Rafiei; Mahmoud Sadeghi Zavare
Journal:  Caspian J Intern Med       Date:  2022

8.  Expression Profile of Cytokines and Enzymes mRNA in Blood Leukocytes of Dogs with Leptospirosis and Its Associated Pulmonary Hemorrhage Syndrome.

Authors:  Carla A Maissen-Villiger; Ariane Schweighauser; H Anette van Dorland; Claudine Morel; Rupert M Bruckmaier; Andreas Zurbriggen; Thierry Francey
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

9.  Cytokine response in human leptospirosis with different clinical outcomes: a systematic review.

Authors:  Indika Senavirathna; Devarajan Rathish; Suneth Agampodi
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

Review 10.  Immune responses to Leptospira infection: roles as biomarkers for disease severity.

Authors:  Chintana Chirathaworn; Sutthikarn Kongpan
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.